NUBEQA® (darolutamide) is a prescription medicine used to treat men with prostate cancer that has not spread to other parts of the body and is no longer responding to a medical or surgical treatment that lowers testosterone.
It is not known if NUBEQA is safe and effective in women and children.
IMPORTANT SAFETY INFORMATION
NUBEQA can harm unborn babies and cause loss of pregnancy. Men with female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA.
Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.
You should not start or stop any medicine without talking to your healthcare provider.
Most common side effects of NUBEQA include:
NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of NUBEQA. Call your doctor for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
For important risk and use information about NUBEQA, please see the full Prescribing Information.